These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1674 related items for PubMed ID: 22984955
1. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. Golden SH, Sapir T. J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955 [Abstract] [Full Text] [Related]
2. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH. Ann Intern Med; 2012 Sep 04; 157(5):336-47. PubMed ID: 22777524 [Abstract] [Full Text] [Related]
3. Golden SH, Brown T, Yeh HC, Maruthur N, Ranasinghe P, Berger Z, Suh Y, Wilson LM, Haberl EB, Bass EB. ; 2012 07 04. PubMed ID: 22876370 [Abstract] [Full Text] [Related]
4. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J. Health Technol Assess; 2016 Feb 04; 20(17):v-xxxi, 1-251. PubMed ID: 26933827 [Abstract] [Full Text] [Related]
5. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis. Keyu G, Jiaqi L, Liyin Z, Jianan Y, Li F, Zhiyi D, Qin Z, Xia L, Lin Y, Zhiguang Z. Front Public Health; 2022 Feb 04; 10():990281. PubMed ID: 36091534 [Abstract] [Full Text] [Related]
6. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2009 Feb 04; 9(20):1-58. PubMed ID: 23074525 [Abstract] [Full Text] [Related]
7. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting. Alamoudi R, Alsubaiee M, Alqarni A, Saleh Y, Aljaser S, Salam A, Eledrisi M. Diabetes Technol Ther; 2017 Jun 04; 19(6):349-354. PubMed ID: 28296467 [Abstract] [Full Text] [Related]
8. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study. Šoupal J, Petruželková L, Grunberger G, Hásková A, Flekač M, Matoulek M, Mikeš O, Pelcl T, Škrha J, Horová E, Škrha J, Parkin CG, Svačina Š, Prázný M. Diabetes Care; 2020 Jan 04; 43(1):37-43. PubMed ID: 31530663 [Abstract] [Full Text] [Related]
9. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review. Matsuda E, Brennan P. JBI Libr Syst Rev; 2012 Jan 04; 10(42 Suppl):1-10. PubMed ID: 27820140 [Abstract] [Full Text] [Related]
10. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L. Acta Diabetol; 2021 Apr 04; 58(4):401-410. PubMed ID: 32789691 [Abstract] [Full Text] [Related]
11. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N. Health Technol Assess; 2010 Feb 04; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123 [Abstract] [Full Text] [Related]
12. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures. Thomas MG, Avari P, Godsland IF, Lett AM, Reddy M, Oliver N. Diabetes Obes Metab; 2021 Nov 04; 23(11):2521-2528. PubMed ID: 34286892 [Abstract] [Full Text] [Related]
13. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump. Rubin RR, Peyrot M. J Diabetes Sci Technol; 2009 Nov 01; 3(6):1402-10. PubMed ID: 20144395 [Abstract] [Full Text] [Related]
14. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D. Diabetes Technol Ther; 2017 Jun 01; 19(S3):S25-S37. PubMed ID: 28585879 [Abstract] [Full Text] [Related]
15. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT. Blair J, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes D, Gamble C. Health Technol Assess; 2018 Aug 01; 22(42):1-112. PubMed ID: 30109847 [Abstract] [Full Text] [Related]
16. Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-Year Follow-Up in the HypoCOMPaSS Randomized Clinical Trial. Speight J, Holmes-Truscott E, Little SA, Leelarathna L, Walkinshaw E, Tan HK, Bowes A, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JAM. Diabetes Technol Ther; 2019 Nov 01; 21(11):619-626. PubMed ID: 31335201 [Abstract] [Full Text] [Related]
17. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials. Pala L, Dicembrini I, Mannucci E. Acta Diabetol; 2019 Sep 01; 56(9):973-980. PubMed ID: 30945047 [Abstract] [Full Text] [Related]
18. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes. Summers JC, Briganti EM, Fitzgerald ZA, Lambers LNJ, Cohen ND. Diabetes Technol Ther; 2019 Aug 01; 21(8):423-429. PubMed ID: 31180239 [Abstract] [Full Text] [Related]
19. Continuous glucose monitoring systems for type 1 diabetes mellitus. Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Cochrane Database Syst Rev; 2012 Jan 18; 1(1):CD008101. PubMed ID: 22258980 [Abstract] [Full Text] [Related]